Why the study?
Does dihydroergotamine prevent profound falls of blood pressure in a patient with idiopathic orthostatic hypotension?
Does dihydroergotamine prevent profound falls of blood pressure in a patient with idiopathic orthostatic hypotension?
Dihydroergotamine at a dose of 20 mg/day was effective in preventing profound falls in blood pressure in a patient with idiopathic orthostatic hypotension.
No takes yet. Share an insight, caveat, or question.
Single-case data support DHE trial in refractory idiopathic orthostatic hypotension; leaves open efficacy and safety without controlled trials.
S. Bajada (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: